Central Trust Company’s Affirm AFRM Stock Holding History

Central Trust Company’s Portfolio AFRM Stock Details AFRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-187	Closed	-$8.57K	–	1573
2026 Q1	$8.57K	Buy	187 +178	+1,978%	+$10.3K	﹤0.01%	1181
2025 Q4	$645	Buy	+9	New	+$648	﹤0.01%	1415

Other funds holding AFRM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Central Trust Company's AFRM Position: Q2 2026 in Review

Central Trust Company sold out of Affirm (AFRM) in Q2 2026, closing a stake of 187 shares — an estimated $8.57K sold.

Central Trust Company first reported a position in AFRM in Q4 2025 and held it in 2 quarters. The position peaked at $8.57K in Q1 2026. 660 funds tracked by Wall St. Rank hold AFRM as of Q2 2026.

Central Trust Company reported no remaining Affirm position as of Q2 2026 after selling out during the quarter.
Central Trust Company sold 187 Affirm shares in Q2 2026, an estimated $8.57K.
Central Trust Company first reported a position in Affirm in Q4 2025 and held it in 2 quarters.
Central Trust Company's Affirm position peaked at $8.57K in Q1 2026.
660 funds tracked by Wall St. Rank held Affirm as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.